Ad
related to: g 6 pd deficiency drug list for children
Search results
Results From The WOW.Com Content Network
Most individuals with G6PD deficiency are asymptomatic.When it induces hemolysis, the effect is usually short-lived. [5]Most people who develop symptoms are male, due to the X-linked pattern of inheritance, but female carriers can be affected due to unfavorable lyonization or skewed X-inactivation, where random inactivation of an X-chromosome in certain cells creates a population of G6PD ...
The selection and use of essential medicines: report of the WHO Expert Committee, 2017 (including the 20th WHO Model List of Essential Medicines and the 6th Model List of Essential Medicines for Children). Geneva: World Health Organization. hdl: 10665/259481. ISBN 978-92-4-121015-7. ISSN 0512-3054. WHO technical report series; no. 1006.
G6PD converts G6P into 6-phosphoglucono-δ-lactone and is the rate-limiting enzyme of the pentose phosphate pathway. Thus, regulation of G6PD has downstream consequences for the activity of the rest of the pentose phosphate pathway. Glucose-6-phosphate dehydrogenase is stimulated by its substrate G6P.
XDH and AOX dual deficiency Xanthine dehydrogenase and aldehyde oxidase combined deficiency XDH deficiency Xanthine dehydrogenase deficiency XDP X-linked dystonia-parkinsonism XDR TB Extensively drug-resistant tuberculosis: XHED X-linked hypohidrotic ectodermal dysplasia: XLMTM X-linked myotubular myopathy: XLOS X-linked Opitz G/BBB syndrome
What links here; Related changes; Upload file; Special pages; Permanent link; Page information; Cite this page; Get shortened URL; Download QR code
Many drugs have more than one name and, therefore, the same drug may be listed more than once. Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs, ranked by sales. Abbreviations are used in the list as follows: INN = International nonproprietary name
Erythropoiesis-stimulating drugs, [3] erythropoietin-type blood factors [2] Use: Anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS [1] [2] ATC code: B03XA: Legal status; In Wikidata
6-Phosphogluconate dehydrogenase (6PGD) is an enzyme in the pentose phosphate pathway (see image). 6PGD catalyzes the reaction of 6-phosphogluconate to an unstable form of 3-keto-6-phosphogluconate, and yields a co-enzyme nicotinamide adenine dinucleotide phosphate (NADPH) as a byproduct. NADPH supplies reducing power to cells.